Viviane Monges

Member of the Novo Holdings Board since 2018.
Chair of the Novo Holdings Audit Committee.

Viviane Monges was born in 1963 and is a French national. She received an MBA from Ecole Supérieure de Commerce de Paris (ESCP). In the beginning of her career, she worked across a wide variety of roles in Asia, Latin America, Europe and the United States.

Viviane Monges has over 30 years of financial management experience, predominantly in the pharmaceutical industry. She joined Wyeth Pharmaceuticals Inc. in 1997 and held several leadership roles, including CFO of the Europe Region unit and CFO of the Global Pharma Business unit. From 2006 to 2010, Viviane Monges was with Novartis A/G as Europe CFO and then as Global Division CFO of the OTC Division. In 2010, she joined Galderma S.A., a multinational dermatology company as Group CFO, which was later acquired by Nestlé S.A. From 2015 to 2018, she served as CFO of the Nestlé Business Excellence Division. Since then, she has been serving on the boards of several health care companies.  

Other Board Positions and Management Duties:

• Board Member and Chair of the Audit Committee, Ferring Pharmaceuticals, Switzerland

• Board Member and Chair of the Audit Committee, ADC Therapeutics, Switzerland

• Board Member and Chair of the Audit Committee, Pharvaris, the Netherlands

• Board Member and Member of the Audit Committee, BioMerieux, France